Our Officers

Dr. Carol Brosgart, MD serves as an independent director on the Boards of both public and privately-held biotechnology companies (Galmed, Abivax,Enochian, Intrivo Diagnostics, and Mirum Pharmaceuticals ) and previously served on the Boards of Juvaris (now Bayer) and Tobira (now Allergan, then AbbVie) until they were acquired; as a consultant to global biopharmaceutical companies (currently Dynavax, Hepion, Moderna, and Pardes Biosciences); as a member of the United States Centers for Disease Control (CDC)/Health and Human Services (HHS) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment, and was the Senior Advisor on Science and Policy to the Division of Viral Hepatitis at the CDC. She has held numerous senior management positions within biotechnology and health care. Dr. Brosgart was the Chief Medical Officer for Alios BioPharma (now Johnson & Johnson), a biotech company developing therapies to treat viral diseases. Dr. Brosgart joined Alios from UCSF Benioff Children’s Hospital & Research Center in Oakland, California, where she served as Senior Vice President and Chief Medical Officer. For eleven years Dr. Brosgart held a number of senior management positions at Gilead Sciences (Vice President, Clinical Research; Vice President, Medical Affairs; and Vice President, Public Health and Policy). While Vice President of Clinical Research at Gilead she was responsible for the clinical development and approval by the FDA and by regulatory authorities worldwide of two antiviral therapies: Viread® for the treatment of HIV, and Hepsera® for the treatment of Chronic Hepatitis B.

She is a member of the Boards of Directors of the Hepatitis B Foundation, the AP Giannini Foundation and the Berkeley Community Scholars. She also serves on the Steering Committee of the HBV Cure Forum of the Forum for Collaborative Research (FCR) at UC Berkeley School of Public Health.

Prior to Gilead, Dr. Brosgart worked for more than 20 years in public health, clinical care, research, and teaching. She was among the first physicians in the United States to recognize and treat patients with HIV/AIDS. Dr. Brosgart was the founding Medical Director of the East Bay AIDS Center at Alta Bates Medical Center in Berkeley, California. She led NIH clinical trials as a member of the Community Programs for Clinical Research on AIDS (CPCRA), chaired the CPCRA Scientific Advisory Committee, and contributed to HIV antiretroviral drug development, and to the development of prophylactic and treatment agents for opportunistic and malignant complications of HIV/AIDS.

Dr. Brosgart received her B.S. in Community Medicine from the University of California, Berkeley (UCB), her M.D. from the University of California, San Francisco (UCSF), and her residency training in Pediatrics (UCSF) and Public Health and Preventive Medicine (UCB). She has published extensively in the areas of infectious diseases, focusing on antiviral therapy for HIV, HBV, CMV, and related public health policy. She is an active member of the Infectious Diseases Society of America (IDSA), the HIV Medical Association (HIVMA) and the American Association for the Study of Liver Disease (AASLD). She is Clinical Professor of Medicine, Biostatistics and Epidemiology at UCSF.

Richard So is the Executive Director of SF Hep B Free – Bay Area, a nonprofit organization in San Francisco, CA dedicated to creating public and healthcare provider awareness about hepatitis B, providing free in-community hepatitis B testing to those who need it, and ensuring access to treatment for chronically infected individuals. Since working at SF Hep B Free, Richard has successfully expanded the program to San Mateo County; increased community education and screening; expanded physician education and created innovative projects to target the most vulnerable populations. He is an active member of both Hep B United and The National Task Force on Hepatitis B Focus on Asian and Pacific Islander Americans (Hep B Task Force). Richard received a Masters in Public Health and Public Policy from Columbia University; has worked as a healthcare consultant; and served in the US Peace Corps as a rural health volunteer in Paraguay. He is excited to bring his myriad of experiences to the Task Force to improve hepatitis B screening, management, and treatment.

Catherine Freeland, MPH, is the Public Health Program Manager at Hepatitis B Foundation in Doylestown, PA. She served as the Treasurer for the Task Force from 2016 – 2018 and Secretary since 2018. Ms. Freeland received her Master of Public Health at East Tennessee State University with a concentration in Community and Behavioral Health. She obtained her Bachelor of Arts degree at Hanover College in Hanover, Indiana. Following her graduation from Hanover College, she spent a year working in Nairobi, Kenya as a Communication and Programming Chair for the Organization of African Instituted Churches. In this position, Ms. Freeland was working to empower, educate, and learn from grassroots community leaders through a train the trainer program. She is interested in reducing health disparities through sustainability projects and collaboration at the community level. As a Frist Field Scholar, Ms. Freeland applied her public health knowledge in Ulaanbaatar, Mongolia through Flagstaff International Relief Effort and the World Health Organization focusing on community outreach and education on viral hepatitis and liver cancer. Ms. Freeland has an increased interest in viral hepatitis prevention and outreach.

Dr. Amy Trang, PhD, MEd is the founder and CEO of Social Capital Solutions, Inc. Social Capital Solutions has been contracted to provide management services for the Task Force since 2014. Dr. Trang is passionate about raising awareness about viral hepatitis screening and linkages to care services because she has family and friends personally affected by it. In addition to the National Task Force on Hepatitis B Focus on Asian and Pacific Islander Americans, she also serves as a Program Development Consultant for HBI-DC and Vice President of Administrative Services and Planning for the Vietnam Viral Hepatitis Alliance.

Dr. Trang completed her doctorate degree in Public Policy from George Mason University School of Public Policy after transferring her doctoral studies in Culture and Values of Education from McGill University (Montreal, Canada). She holds a master’s degree in Social and Psychological Foundations of Education from the University of Virginia (UVA) School of Education and Human Development, and a bachelor’s degree in International Studies from George Mason University. She has also been an adjunct faculty at UVA since 2000, where she has taught Sociology of Education, Education in Multicultural Societies, Anthropology of Education, Critical Education Policy, Comparative Education, and Asian Education.

The responsibilities for this position are currently being shared by the Co-Chairs, Secretary, and Administrator.